Efficacy of bevacizumab with cisplatin and gemcitabine in Asian patients with advanced or recurrent non-squamous non-small cell lung cancer who have not received prior chemotherapy: A substudy of the Avastin in Lung trial

Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)

(2010) M. Reck et al.   ANNALS OF ONCOLOGY

Progression-Free Survival

(2010) David Lebwohl et al.   CANCER JOURNAL

Optimizing the management of advanced non-small-cell lung cancer: a personal view

(2010) Mark D. Vincent   Current Oncology

Use of a Population-Based Cancer Registry to Calculate Twenty-Year Trends in Cancer Incidence and Mortality in Fukui Prefecture

(2010) Masakazu Hattori et al.   JOURNAL OF EPIDEMIOLOGY

First-line single agent treatment with gefitinib in patients with advanced non-small-cell lung cancer

(2010) Yong-Mei Yin et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Asian Ethnicity Is a Favorable Prognostic Factor for Overall Survival in Non-small Cell Lung Cancer (NSCLC) and Is Independent of Smoking Status

(2010) Sai-Hong Ignatius Ou et al.   Journal of Thoracic Oncology

Japanese Ethnicity Compared with Caucasian Ethnicity and Never-Smoking Status Are Independent Favorable Prognostic Factors for Overall Survival in Non-small Cell Lung Cancer: A Collaborative Epidemiologic Study of the National Hospital Organization Study Group for Lung Cancer (NHSGLC) in Japan and a Southern California Regional Cancer Registry Databases

(2010) Tomoya Kawaguchi et al.   Journal of Thoracic Oncology

Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study

(2010) Lucio Crinò et al.   LANCET ONCOLOGY

Years of life lost due to cancer in a cohort study in Japan

(2009) T.-M. Pham et al.   EUROPEAN JOURNAL OF PUBLIC HEALTH

Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL

(2009) Martin Reck et al.   JOURNAL OF CLINICAL ONCOLOGY

Overview of Gefitinib in Non-small Cell Lung Cancer: An Asian Perspective

(2008) H. Jiang   JAPANESE JOURNAL OF CLINICAL ONCOLOGY